(Post-pandemic Era)-Global Therapeutic Vaccines Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2023

Report ID: 271300 | Published Date: Jan 2025 | No. of Page: 83 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Therapeutic Vaccines Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Peptide Therapeutic Vaccine -Product Introduction and Major Manufacturers
      1.1.2 Cell Therapeutic Vaccine -Product Introduction and Major Manufacturers
      1.1.3 Nucleic Acid Therapeutic Vaccine -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
    2.1 Regional Market Share in Terms of Production (2020-2027)
    2.2 Regional Market Share in Terms of Revenue (2020-2027)
    2.3 Regional Market Share in Terms of Consumption (2020-2027)
3 Global Therapeutic Vaccines Market Assessment by Type
    3.1 Global Therapeutic Vaccines Production by Type (2016-2027)
    3.2 Global Therapeutic Vaccines Revenue by Type (2016-2027)
    3.3 North America Therapeutic Vaccines Production and Revenue by Type (2016-2027)
    3.4 Asia Therapeutic Vaccines Production and Revenue by Type (2016-2027)
    3.5 Europe Therapeutic Vaccines Production and Revenue by Type (2016-2027)
    3.6 Middle East & Africa Therapeutic Vaccines Production and Revenue by Type (2016-2027)
    3.7 South America Therapeutic Vaccines Production and Revenue by Type (2016-2027)

4 Global Therapeutic Vaccines Market Assessment by Application
    4.1 Historical & Forecast Global Therapeutic Vaccines Consumption, Different Application Field (2016-2027)
    4.2 Historical & Forecast North America Therapeutic Vaccines Consumption, Different Application Field (2016-2027)
    4.3 Historical & Forecast Asia Therapeutic Vaccines Consumption, Different Application Field (2016-2027)
    4.4 Historical & Forecast Europe Therapeutic Vaccines Consumption, Different Application Field (2016-2027)
    4.5 Historical & Forecast Middle East & Africa Therapeutic Vaccines Consumption, Different Application Field (2016-2027)
    4.6 Historical & Forecast South America Therapeutic Vaccines Consumption, Different Application Field (2016-2027)

5 North America
    5.1 US Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    5.2 Canada Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    5.3 Mexico Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6 Asia
    6.1 China Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.2 Japan Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.3 India Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.4 Korea Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.5 Southeat Asia Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7 Europe
    7.1 Germany Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.2 UK Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.3 France Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.4 Russia Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.5 Italy Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8 Middle East and Africa
    8.1 Saudi Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.2 UAE Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.3 Egypt Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.4 Nigeria Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.5 South Africa Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9 South America
    9.1 Brazil Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    9.2 Argentina Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    9.3 Colombia Therapeutic Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
10 Global Therapeutic Vaccines Average Price Trend
    10.1 Market Price for Each Type of Therapeutic Vaccines in North America (2016-2027)
    10.2 Market Price for Each Type of Therapeutic Vaccines in Asia (2016-2027)
    10.3 Market Price for Each Type of Therapeutic Vaccines in Europe (2016-2027)
    10.4 Market Price for Each Type of Therapeutic Vaccines in Middle East & Africa (2016-2027)
    10.5 Market Price for Each Type of Therapeutic Vaccines in South America (2016-2027)

11 Value Chain (Impact of COVID-19)
    11.1 Therapeutic Vaccines Value Chain Analysis
      11.1.1 Upstream
      11.1.2 Downstream
    11.2 COVID-19 Impact on Therapeutic Vaccines Industry
      11.2.1 Industrial Policy Issued Under the Epidemic Situation
    11.3 Cost-Under the Epidemic Situation
      11.3.1 Cost of Raw Material
    11.4 Channel Analysis
      11.4.1 Distribution Channel-Under the Epidemic Situation
      11.4.2 Distributors

12 Therapeutic Vaccines Competitive Analysis
     12.1 Northeast Biotherapeutics
        12.1.1 Northeast Biotherapeutics Company Profiles
        12.1.2 Northeast Biotherapeutics Product Introduction
        12.1.3 Northeast Biotherapeutics Therapeutic Vaccines Production, Revenue (2015-2020)
        12.1.4 SWOT Analysis
     12.2 Agenus
        12.2.1 Agenus Company Profiles
        12.2.2 Agenus Product Introduction
        12.2.3 Agenus Therapeutic Vaccines Production, Revenue (2015-2020)
        12.2.4 SWOT Analysis
     12.3 Vaccinogen Inc
        12.3.1 Vaccinogen Inc Company Profiles
        12.3.2 Vaccinogen Inc Product Introduction
        12.3.3 Vaccinogen Inc Therapeutic Vaccines Production, Revenue (2015-2020)
        12.3.4 SWOT Analysis
     12.4 CIMAB S.A
        12.4.1 CIMAB S.A Company Profiles
        12.4.2 CIMAB S.A Product Introduction
        12.4.3 CIMAB S.A Therapeutic Vaccines Production, Revenue (2015-2020)
        12.4.4 SWOT Analysis
        12.5.1 Dendreon Company Profiles
        12.5.2 Dendreon Product Introduction
        12.5.3 Dendreon Therapeutic Vaccines Production, Revenue (2015-2020)
        12.5.4 SWOT Analysis
     12.6 Corixa
        12.6.1 Corixa Company Profiles
        12.6.2 Corixa Product Introduction
        12.6.3 Corixa Therapeutic Vaccines Production, Revenue (2015-2020)
        12.6.4 SWOT Analysis
     12.7 AVAX
        12.7.1 AVAX Company Profiles
        12.7.2 AVAX Product Introduction
        12.7.3 AVAX Therapeutic Vaccines Production, Revenue (2015-2020)
        12.7.4 SWOT Analysis
13 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2020)
    Figure Global Therapeutic Vaccines Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2016-2027)
    Table Regional Market Share in Terms of Production (2020-2027)
    Figure Regional Market Share in Terms of Production (2019 - 2020)
    Table Regional Market Share in Terms of Revenue (2020-2027)
    Figure Regional Market Share in Terms of Revenue (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Table Global Therapeutic Vaccines Production (K Unit) by Type (2016-2027)
    Figure Global Therapeutic Vaccines Production (K Unit) and Growth Rate (2016-2027)
    Figure Global Therapeutic Vaccines Production Market Share (%) by Type (2019 -2020)
    Table Global Therapeutic Vaccines Revenue (Million USD) by Type (2016-2027)
    Figure Global Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Global Therapeutic Vaccines Revenue Market Share (%) by Type (2019-2020)
    Figure North America Therapeutic Vaccines Production (K Unit) by Type (2016-2027)
    Figure North America Therapeutic Vaccines Production (K Unit) and Growth Rate (2016-2027)
    Figure North America Therapeutic Vaccines Revenue (Million USD) by Type (2016-2027)
    Figure North America Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Asia Therapeutic Vaccines Production (K Unit) by Type (2016-2027)
    Figure Asia Therapeutic Vaccines Production (K Unit) and Growth Rate (2016-2027)
    Figure Asia Therapeutic Vaccines Revenue (Million USD) by Type (2016-2027)
    Figure Asia Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Europe Therapeutic Vaccines Production (K Unit) by Type (2016-2027)
    Figure Europe Therapeutic Vaccines Production (K Unit) and Growth Rate (2016-2027)
    Figure Europe Therapeutic Vaccines Revenue (Million USD) by Type (2016-2027)
    Figure Europe Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Middle East & Africa Therapeutic Vaccines Production (K Unit) by Type (2016-2027)
    Figure Middle East & Africa Therapeutic Vaccines Production (K Unit) and Growth Rate (2016-2027)
    Figure Middle East & Africa Therapeutic Vaccines Revenue (Million USD) by Type (2016-2027)
    Figure Middle East & Africa Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
    Figure South America Therapeutic Vaccines Production (K Unit) by Type (2016-2027)
    Figure South America Therapeutic Vaccines Production (K Unit) and Growth Rate (2016-2027)
    Figure South America Therapeutic Vaccines Revenue (Million USD) by Type (2016-2027)
    Figure South America Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
    Table Historical & Forecast Therapeutic Vaccines Different Application Field Consumption (K Unit)
    Figure Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Different Application Field Consumption Market Share (%) (2019-2020)
    Table Historical & Forecast Therapeutic Vaccines Different Application Field Consumption (K Unit)
    Figure North America Therapeutic Vaccines Consumption (K Unit) and Growth Rate (2016-2027)
    Figure North America Therapeutic Vaccines Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Therapeutic Vaccines Different Application Field Consumption (K Unit)
    Figure Asia Therapeutic Vaccines Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Asia Therapeutic Vaccines Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Therapeutic Vaccines Different Application Field Consumption (K Unit)
    Figure Europe Therapeutic Vaccines Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Europe Therapeutic Vaccines Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Therapeutic Vaccines Different Application Field Consumption (K Unit)
    Figure Middle East & Africa Therapeutic Vaccines Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Middle East & Africa Therapeutic Vaccines Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Therapeutic Vaccines Different Application Field Consumption (K Unit)
    Figure South America Therapeutic Vaccines Consumption (K Unit) and Growth Rate (2016-2027)
    Figure South America Therapeutic Vaccines Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Therapeutic Vaccines Different Application Field Consumption (K Unit)
    Table US Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Canada Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Mexico Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table China Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Japan Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table India Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Korea Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Southeast Asia Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Germany Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UK Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table France Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Russia Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Italy Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Saudi Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UAE Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Egypt Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Nigeria Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table South Africa Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Brazil Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Argentina Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Colombia Therapeutic Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Market Price (USD/Unit) for Each Type of Therapeutic Vaccines in China
    Table Market Price (USD/Unit) for Each Type of Therapeutic Vaccines in EU
    Table Market Price (USD/Unit) for Each Type of Therapeutic Vaccines in USA
    Table Market Price (USD/Unit) for Each Type of Therapeutic Vaccines in Japan
    Table Market Price (USD/Unit) for Each Type of Therapeutic Vaccines in India
    Table Market Price (USD/Unit) for Each Type of Therapeutic Vaccines in Southeast Asia
    Table Market Price (USD/Unit) for Each Type of Therapeutic Vaccines in South America
    Figure Value Chain Structure of Therapeutic Vaccines
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Therapeutic Vaccines
    Figure Cost Structure of Therapeutic Vaccines in 2020
    Table Distributors/Traders List
    Table Northeast Biotherapeutics Profiles
    Table Northeast Biotherapeutics Therapeutic Vaccines Product Introduction
    Figure Northeast Biotherapeutics Therapeutic Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Northeast Biotherapeutics SWOT Analysis
    Table Agenus Profiles
    Table Agenus Therapeutic Vaccines Product Introduction
    Figure Agenus Therapeutic Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Agenus SWOT Analysis
    Table Vaccinogen Inc Profiles
    Table Vaccinogen Inc Therapeutic Vaccines Product Introduction
    Figure Vaccinogen Inc Therapeutic Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Vaccinogen Inc SWOT Analysis
    Table CIMAB S.A Profiles
    Table CIMAB S.A Therapeutic Vaccines Product Introduction
    Figure CIMAB S.A Therapeutic Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure CIMAB S.A SWOT Analysis
    Table Dendreon Profiles
    Table Dendreon Therapeutic Vaccines Product Introduction
    Figure Dendreon Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Dendreon SWOT Analysis
    Table Corixa Profiles
    Table Corixa Therapeutic Vaccines Product Introduction
    Figure Corixa Therapeutic Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Corixa SWOT Analysis
    Table AVAX Profiles
    Table AVAX Therapeutic Vaccines Product Introduction
    Figure AVAX Therapeutic Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global Therapeutic Vaccines Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global Therapeutic Vaccines Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global Therapeutic Vaccines Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports